1. Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, University Park, Nottingham, United Kingdom;
2. Archimedes Development Limited, Albert Einstein Centre, Nottingham Science and Technology Park, University Boulevard, Nottingham, United Kingdom;
3. Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom